Inozyme Pharma Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
Inozyme Pharma is a biotechnology research company based in Boston, Massachusetts, focused on rare diseases impacting bone health and blood vessel function. It operates as a clinical-stage biopharmaceutical company developing therapeutics for these conditions, with INZ-701 as its lead candidate. INZ-701 is an ENPP1 Fc fusion protein designed to function as an enzyme replacement therapy aimed at increasing PPi and adenosine levels, enabling potential treatment of diseases caused by deficiencies in these metabolites. The program is in clinical development for ENPP1 Deficiency, ABCC6 Deficiency, and calciphylaxis, reflecting its focus on rare diseases. The company, which has 11-50 employees, is located at 321 Summer Street Suite 400, Boston, MA 02210, and maintains a website at inozyme.com.